Inhaled triamcinolone and chronic obstructive pulmonary disease

Comment

A De Maria et al. N Engl J Med. 2001.

. 2001 May 17;344(20):1553-4; author reply 1554-6.

doi: 10.1056/NEJM200105173442013.

No abstract available

Comment on

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M. Liberman UA, et al. N Engl J Med. 1995 Nov 30;333(22):1437-43. doi: 10.1056/NEJM199511303332201. N Engl J Med. 1995. PMID: 7477143 Clinical Trial.
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.
Lung Health Study Research Group; Wise R, Connett J, Weinmann G, Scanlon P, Skeans M. Lung Health Study Research Group, et al. N Engl J Med. 2000 Dec 28;343(26):1902-9. doi: 10.1056/NEJM200012283432601. N Engl J Med. 2000. PMID: 11136260 Clinical Trial.